Calls
Source: S&P Capital IQ transcripts via Xpressfeed · latest indexed call 2026-06-04 · generated 2026-07-24.
Latest call digest
DocuSign, Inc., Q1 2027 Earnings Call, Jun 04, 2026 · 2026-06-04T21:00:00
Q1 fiscal 2027, reported June 4, 2026. Prepared remarks were a clean beat-and-hold. Revenue of $830 million grew 9% year-over-year, non-GAAP operating margin reached 32.0% versus a 29.5% comparison, free cash flow was $289 million at a 35% margin, and the company repurchased $318 million of stock — its largest quarterly buyback on record. IAM reached 12.6% of total ARR from 10.8% the prior quarter, with 40,000 companies on the platform. Dollar net retention was over 102%, and customers spending above $300,000 in ACV grew 12% to 1,258, which management called the first double-digit growth in that metric in three years.
Guidance actually stated. The full-year ARR growth range of 8.25% to 8.75% and the roughly 18% IAM share of ARR at year-end were both reiterated unchanged from the Q4 call. Q2 revenue was guided to $865 million to $869 million and fiscal 2027 to $3.490 billion to $3.502 billion. The one raise was profitability: fiscal 2027 operating margin moved to 30.5% to 31.0%, described as an increase of 0.5% at the midpoint versus prior guidance. Gross margin guidance was unchanged and still reflects the tail of the cloud migration.
Where Q&A diverged. Analysts spent less time on the beat than on its size and shape. Rob Owens noted the beat was smaller than historical and that no discrete subscription revenue number was given; Tyler Radke made the same point about subscription revenue and billings looking lighter than normal. Patrick Walravens pressed hardest, saying he would have liked to see double digits by now and that on an FX-adjusted basis growth may have decelerated sequentially — Thygesen replied that no timeline had been set and did not name anything that had proved harder, while Grayson pointed to the prior-year digital add-on comparison. Two separate attempts to get a number on the IAM consumption or ARPC uplift were declined. The company also did not update the ARR guide one quarter into the year, consistent with the philosophy Grayson laid out in March.
Other management points that matter. Enterprise is where the incremental news sat: IAM bookings grew faster year-over-year in North America enterprise than in any other segment, the IAM Platform Plan credit-based pricing model went to general availability in April after a beta, and MCP connections to Anthropic Claude, Gemini and OpenAI ChatGPT were positioned alongside integrations with Coupa, Workday, Greenhouse, Slack and Stripe. Headcount fell sequentially to 6,991, and management declined to guide headcount for the year.
Participant coverage from the latest call.
| Group | Participants | Count |
|---|---|---|
| Management | Operator; Matt Sonefeldt — Head of Investor Relations, DocuSign, Inc.; Allan Thygesen — President, CEO & Director, DocuSign, Inc.; Blake Grayson — Executive VP & CFO, DocuSign, Inc. | 4 |
| Analysts | Robbie Owens — MD & Senior Research Analyst, Piper Sandler & Co., Research Division; Michael Turrin — Equity Analyst, Wells Fargo Securities, LLC, Research Division; Rishi Jaluria — MD & Information Technology Equity Research Analyst, RBC Capital Markets, Research Division; Patrick Walravens — MD, Director of Technology Research & Equity Research Analyst, Citizens JMP Securities, LLC, Research Division; Tyler Radke — VP & Senior Analyst, Citigroup Inc., Research Division; Unknown Analyst; Patrick McIlwee — Research Analyst, William Blair & Company L.L.C., Research Division; Scott Berg — Senior Analyst, Needham & Company, LLC, Research Division; Brent Thill — MD & Tech Sector Equity Analyst, Jefferies LLC, Research Division; Jacob Gideon — Research Analyst, BofA Securities, Research Division; Allan M. Verkhovski — Application Software Analyst, BTIG, LLC, Research Division | 11 |
Curated latest-call exchanges; one row per analyst topic.
| Analyst | Firm | Topic | What changed in Q&A |
|---|---|---|---|
| Patrick Walravens | Citizens JMP Securities, LLC, Research Division | Why growth is not yet double digits; possible FX-adjusted sequential deceleration | The hardest exchange on the call. Thygesen said no timeline had ever been set and described himself as pleased rather than disappointed, without identifying what had been harder than expected. Grayson then argued the apparent deceleration reflects the prior-year digital add-on comparison and FX, and that normalized growth is roughly in line. |
| Robbie Owens | Piper Sandler & Co., Research Division | Size of the beat and the shape of the quarter | Owens observed the beat was smaller than historically and that no discrete subscription revenue figure was provided. Grayson said he had no concerns with where the quarter landed and attributed the narrower beat to more precise forecasting as operational maturity improves. |
| Robbie Owens | Piper Sandler & Co., Research Division | Quantifying the eSignature consumption lift from IAM adoption | Asked twice for a metric. Thygesen called the lift significant and meaningful but declined to disclose a percentage, and said the company does not intend to start disclosing one. |
| Tyler Radke | Citigroup Inc., Research Division | $300,000-plus ACV strength versus lighter subscription revenue and billings | Grayson reminded analysts billings is no longer guided and is volatile on timing, said billings came in as expected, and redirected to the full-year ARR guide as the outlook that matters. |
| Tyler Radke | Citigroup Inc., Research Division | Confidence in the 8.5% ARR guide versus 90 days ago, and linearity of the IAM ramp | Thygesen answered that a full-year ARR guide is effectively a Q4 guide, that visibility builds through the year, and that the guide would be updated as the year progresses. On IAM linearity he called a linear progression a relatively safe assumption but declined to endorse it as a target. |
| Unknown Analyst (Jason, on for Alex Zukin) | Wolfe Research, LLC | Deriving IAM ARPC uplift from disclosed IAM ARR and customer counts | The analyst walked through his own math implying a high single-digit uplift. Grayson pushed back on the framing, arguing IAM is a platform shift rather than a separate product and that per-customer arithmetic is not the right lens, without confirming or correcting the number. |
| Michael Turrin | Wells Fargo Securities, LLC, Research Division | Positioning versus the frontier LLM providers Docusign is partnering with | Thygesen framed the partnerships as an extension of a long-standing API and ISV distribution strategy and cited private consented agreement data, cross-functional workflow breadth and trust as the moat. He said several of the model-provider partnerships originated as inbound inquiries. |
| Patrick McIlwee | William Blair & Company L.L.C., Research Division | Competing against CLM vendors and broader workflow platforms | Thygesen conceded the CLM space has several vendors and is evolving, argued the IAM opportunity is materially wider than CLM, and pointed to partnerships with Harvey, Legora and CoCounsel Legal by Thomson Reuters as coexistence rather than head-to-head competition. |
| Allan M. Verkhovski | BTIG, LLC, Research Division | Direction of net revenue retention on a constant-currency basis | Grayson said FX is not a major mover in the metric, repeated that DNR has improved sequentially for several quarters, and then qualified that on a rounded basis it has been flat for the past few — a more measured framing than the prepared remarks. |
| Brent Thill | Jefferies LLC, Research Division | Whether headcount will be down for the full year | The question was directed to Grayson but answered by Thygesen, who declined to guide headcount, said he would be comfortable with headcount rising slightly, and redirected to operating expense growth relative to revenue. |
Theme tracker
Themes are curator-classified across supplied calls.
| Theme | Status | Quarters mentioned | Read-through |
|---|---|---|---|
| IAM as the designated growth engine | persisted | Q1 2025, Q2 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026, Q3 2026, Q4 2026, Q1 2027 | Present in every prepared remark since the platform was unveiled, and the disclosure has ratcheted from qualitative deal-volume commentary to a guided percentage of ARR. The framing has been consistent, which makes the guided IAM share the cleanest scorecard the company has given itself. |
| Enterprise and upmarket expansion of IAM | persisted | Q3 2025, Q4 2025, Q1 2026, Q2 2026, Q3 2026, Q4 2026, Q1 2027 | Introduced as departmental-level enterprise availability, then a top-down C-suite motion, then credit-based platform pricing. Management has described it as early on every one of these calls, which is a long run of the same qualifier. |
| Gross retention and dollar net retention improvement | persisted | Q2 2024, Q3 2024, Q4 2024, Q1 2025, Q2 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026, Q3 2026, Q4 2026, Q1 2027 | The through-line of the whole history: DNR fell to a stated low of 98%, was described as stabilized, then improved to 101%, 102% and over 102%. Management still attributes most of the gain to gross retention rather than IAM expansion. |
| Cloud data centre migration as a gross margin headwind | persisted | Q4 2024, Q1 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026, Q3 2026, Q4 2026, Q1 2027 | Flagged well in advance and repeatedly re-dated. The Q1 2027 call says the majority of site migrations are complete while still guiding full-year gross margin down slightly, so the headwind is narrowing rather than gone. |
| Buyback as the primary use of free cash flow | persisted | Q2 2024, Q3 2024, Q4 2024, Q1 2025, Q2 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026, Q3 2026, Q4 2026, Q1 2027 | Repurchase size has been described as a record in several consecutive quarters, with authorization raised repeatedly. M&A has been discussed as active but has produced one named deal, Lexion, in the reviewed history. |
| Distribution through frontier AI assistants and MCP | emerged | Q3 2026, Q4 2026, Q1 2027 | Absent before the Q3 2026 call and now a headline element of the prepared remarks and of analyst questions. It is presented as distribution and as a competitive answer at the same time, which is why analysts keep probing whether the model providers are partners or eventual substitutes. |
| Billings as a reported metric and early-renewal timing | dropped | Q2 2024, Q3 2024, Q4 2024, Q1 2025, Q2 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026, Q3 2026, Q4 2026 | Dominated guidance and Q&A for the entire history up to Q4 2026, which management flagged as the last billings report. Q1 2027 carries no billings guide and no early-renewal discussion in prepared remarks; the metric was retired after a quarter in which timing caused a guidance miss, so the reader should treat the change as both a simplification and a loss of a check on bookings. |
| Macro and customer spending scrutiny | dropped | Q2 2024, Q3 2024, Q4 2024, Q1 2025, Q2 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026, Q3 2026 | A standing question on every call from Q2 2024 through Q3 2026, including explicit tariff, interest-rate and public-sector versions, and a stated reason for added guidance conservatism in Q1 2026. Neither the Q4 2026 nor the Q1 2027 call contains a macro question or a macro caveat in guidance commentary. |
Guidance ledger
Quotes, calls, and speakers are source-verified; outcomes are curator-classified.
| Verbatim guidance | Call | Speaker | Curator outcome | Outcome note |
|---|---|---|---|---|
| “For billings, we expect $741 million to $751 million in Q1 or a 5% year-over-year growth rate at the midpoint” | DocuSign, Inc., Q4 2025 Earnings Call, Mar 13, 2025 · 2025-03-13T21:00:00 | Blake Grayson | missed | The Q1 2026 call reported billings of $740 million, up 4% year-over-year, and management stated billings ended slightly below the guidance range, attributing it to early renewals arriving sooner than forecast rather than demand. |
| “we expect full year fiscal 2026 billings between $3.300 billion to $3.354 billion or a 7% year-over-year growth rate at the midpoint” | DocuSign, Inc., Q4 2025 Earnings Call, Mar 13, 2025 · 2025-03-13T21:00:00 | Blake Grayson | kept | The Q4 2026 call reported full-year fiscal 2026 billings of $3.4 billion, up 10% year-over-year, above the original range despite the Q1 shortfall. |
| “We expect this IAM contribution to grow this fiscal year and anticipate it representing a low double-digit percentage share of our total subscription recurring revenue book of business by Q4 of fiscal 2026.” | DocuSign, Inc., Q4 2025 Earnings Call, Mar 13, 2025 · 2025-03-13T21:00:00 | Blake Grayson | kept | The Q4 2026 call reported IAM at over $350 million in ARR, or 10.8% of total company ARR, up from 2.3% at the end of fiscal 2025. Note the reporting base changed from subscription book of business to total ARR during the year. |
| “We expect non-GAAP operating margin between 26.5% to 27.5% for Q2 and 27.8% to 28.8% for fiscal 2026, unchanged for the full year.” | DocuSign, Inc., Q1 2026 Earnings Call, Jun 05, 2025 · 2025-06-05T21:00:00 | Blake Grayson | kept | Full-year fiscal 2026 non-GAAP operating margin was reported at 30%, above the guided range; Q2 fiscal 2026 operating margin came in at 29.8%. |
| “For billings, we expect $785 million to $795 million in Q3, or a 5% year-over-year growth rate at the midpoint” | DocuSign, Inc., Q2 2026 Earnings Call, Sep 04, 2025 · 2025-09-04T21:00:00 | Blake Grayson | kept | Q3 fiscal 2026 billings were $829 million, up 10% year-over-year. Management said roughly half the outperformance came from renewal timing and early renewal strength. |
| “we expect total revenue of $825 million to $829 million in Q4 or a 7% year-over-year increase at the midpoint and $3.208 billion to $3.212 billion for fiscal 2026 or an 8% year-over-year increase at the midpoint” | DocuSign, Inc., Q3 2026 Earnings Call, Dec 04, 2025 · 2025-12-04T22:00:00 | Blake Grayson | kept | Q4 fiscal 2026 revenue was $837 million, up 8% year-over-year, and full-year revenue was $3.2 billion, up 8%. |
| “For billings, we expect $992 million to $1.002 billion in Q4 or an 8% growth rate year-over-year at the midpoint” | DocuSign, Inc., Q3 2026 Earnings Call, Dec 04, 2025 · 2025-12-04T22:00:00 | Blake Grayson | kept | Q4 fiscal 2026 billings exceeded $1 billion for the first time, growing 10% year-over-year. Management said about half the outperformance versus guidance was timing, with the remainder from FX and bookings. |
| “we expect $822 million to $826 million in Q1 or an 8% year-over-year increase at the midpoint” | DocuSign, Inc., Q4 2026 Earnings Call, Mar 17, 2026 · 2026-03-17T21:00:00 | Blake Grayson | kept | Q1 fiscal 2027 revenue was $830 million, up 9% year-over-year, with an approximately 1.6 percentage point benefit from foreign exchange rates. |
| “We expect a year-over-year growth rate range of 8.25% to 8.75% or an 8.5% year-over-year increase to $3.551 billion at the midpoint at the end of Q4 of fiscal 2027.” | DocuSign, Inc., Q4 2026 Earnings Call, Mar 17, 2026 · 2026-03-17T21:00:00 | Blake Grayson | pending | Reiterated unchanged on the Q1 2027 call. Management said it intends to revise the ARR forecast only as full-year bookings expectations evolve, and that visibility builds later in the year given second-half weighting. |
| “We expect IAM to represent approximately 18% of our total ARR at the end of Q4 fiscal 2027, driving IAM to well over $600 million in ARR by the end of this year.” | DocuSign, Inc., Q4 2026 Earnings Call, Mar 17, 2026 · 2026-03-17T21:00:00 | Blake Grayson | pending | Reiterated on the Q1 2027 call, where IAM reached 12.6% of total ARR, up from 10.8% the prior quarter. |
| “For revenue, we expect $865 million to $869 million in Q2 or an 8% year-over-year increase at the midpoint and $3.490 billion to $3.502 billion for fiscal 2027 or a 9% year-over-year increase at the midpoint.” | DocuSign, Inc., Q1 2027 Earnings Call, Jun 04, 2026 · 2026-06-04T21:00:00 | Blake Grayson | pending | Management flagged a harder Q2 comparison, noting Q2 of fiscal 2026 was the highest quarterly growth of that year, driven mostly by higher digital usage. |
| “We expect non-GAAP operating margin to reach 29.7% to 30.2% for Q2 and 30.5% to 31.0% for fiscal 2027, an increase of 0.5% at the midpoint versus prior guidance.” | DocuSign, Inc., Q1 2027 Earnings Call, Jun 04, 2026 · 2026-06-04T21:00:00 | Blake Grayson | pending | The only guidance raise on the Q1 2027 call. Q1 outperformance was attributed to four roughly equal components, one of which was an insurance legal reimbursement related to prior periods. |
Q&A pressure map
Question counts and firms are curator tallies; analyst coverage shown above.
| Topic | Questions | Firms | Pressure / response |
|---|---|---|---|
| Enterprise IAM traction and go-to-market readiness | 19 | William Blair & Company L.L.C., Research Division, Citigroup Inc., Research Division, Wolfe Research, LLC, BofA Securities, Research Division, Jefferies LLC, Research Division, Morgan Stanley, Research Division, Citizens JMP Securities, LLC, Research Division, Evercore ISI Institutional Equities, Research Division, Wells Fargo Securities, LLC, Research Division | The most persistent line of questioning across the reviewed window: whether the sales force, partner channel and product are actually ready for large-enterprise deployments rather than departmental lands. Management has answered consistently and candidly, but has described the effort as early on every call from Q3 2025 through Q1 2027. |
| Billings volatility, early-renewal timing and the move to ARR reporting | 18 | Citigroup Inc., Research Division, Morgan Stanley, Research Division, Wolfe Research, LLC, William Blair & Company L.L.C., Research Division, Wells Fargo Securities, LLC, Research Division, Robert W. Baird & Co. Incorporated, Research Division, Piper Sandler & Co., Research Division, Citizens JMP Securities, LLC, Research Division, JPMorgan Chase & Co, Research Division | Concentrated on the Q1 2026 call, where the billings miss drew questions from most of the covering firms, including Pat Walravens asking directly when management knew billings would come in below guidance. Michael Turrin asked on that same call whether ARR should replace billings; the company announced exactly that change on the Q3 2026 call. |
| Quantifying the IAM uplift and expansion economics | 10 | Evercore ISI Institutional Equities, Research Division, Jefferies LLC, Research Division, Morgan Stanley, Research Division, William Blair & Company L.L.C., Research Division, RBC Capital Markets, Research Division, Piper Sandler & Co., Research Division, Wolfe Research, LLC | Asked in some form on most calls since Q4 2025 and refused every time. Management describes the uplift as meaningful, significant or accretive but has never given a rate. On the latest call Rob Owens asked twice in a row and was told the company does not intend to start disclosing it, so investors are still modelling the central IAM economics from inference. |
| Macro and demand environment | 10 | Morgan Stanley, Research Division, Evercore ISI Institutional Equities, Research Division, Jefferies LLC, Research Division, BofA Securities, Research Division, JPMorgan Chase & Co, Research Division, Wells Fargo Securities, LLC, Research Division, Citigroup Inc., Research Division, Piper Sandler & Co., Research Division | Recurring through Q3 2026 and answered the same way each time: no material impact visible in envelope volumes or consumption, with real estate consistently named as the slower vertical. The line of questioning disappears entirely on the Q4 2026 and Q1 2027 calls. |
| Timing and credibility of the double-digit growth goal | 6 | Jefferies LLC, Research Division, Wolfe Research, LLC, William Blair & Company L.L.C., Research Division, BTIG, LLC, Research Division, Citizens JMP Securities, LLC, Research Division | Asked roughly once a year by different firms and never answered with a date. On the Q4 2026 call Grayson said the timing was not as important to him at the moment and that there was nothing to share on a timeline; on the Q1 2027 call Walravens asked what had been harder than expected and Thygesen answered about not having set a timeline rather than naming an obstacle. Both answers plainly leave the direct question unaddressed. |
| Competitive position versus LLM providers and CLM vendors | 6 | Citizens JMP Securities, LLC, Research Division, RBC Capital Markets, Research Division, JPMorgan Chase & Co, Research Division, Wells Fargo Securities, LLC, Research Division, William Blair & Company L.L.C., Research Division | Rising in frequency as the model partnerships expand. Rishi Jaluria framed it explicitly as investor worry about competition from do-it-yourself use of those platforms or from the platforms themselves. Management's answer is stable across calls: consented private agreement data, cross-functional workflow coverage and trust. |
Language shifts
Only language evidence verified against the referenced component is shown.
| Observation | Verbatim evidence | Call ID | Component |
|---|---|---|---|
| The clearest caution language in the reviewed history sits in Q1 2026, where management explicitly widened its own forecasting assumptions after the billings miss. This is the only instance of an announced change in forecasting posture. | “We will take a more conservative approach to forecasting the timing of early renewals for the remainder of fiscal 2026 in light of the go-to-market changes.” | 1943712123 | 3 |
| Macro caveats were still being written into guidance commentary in Q1 2026. No equivalent hedge appears in the Q4 2026 or Q1 2027 guidance sections, which is a change in register rather than a stated change in view. | “While we do not see any material macro impact on our Q1 results, we are taking a cautious approach for the remainder of fiscal 2026 given the uncertain economic environment.” | 1943712123 | 3 |
| Q3 2026 marks the retirement of the metric that had generated the most Q&A friction. The company framed it as investor-driven transparency; it also removes the disclosure that produced the Q1 2026 guidance miss. | “Finally, as previously discussed, we will no longer report billings in fiscal 2027.” | 1970296676 | 3 |
| Confidence vocabulary steps up in Q4 2026. Prior calls used aspiration language about reaccelerating; this is a direct positioning statement, and it was made in the same breath as the first formal ARR guide. | “We are positioned to begin accelerating the business.” | 1986335804 | 2 |
| Against that confidence, the IAM retention evidence is still hedged. Grayson twice qualified the favourable renewal-cohort data by its sample size on the same call. | “I'm going to preface this by a very early days of our first renewal cohort. So the sample size is pretty small.” | 1986335804 | 23 |
| On the latest call the prepared remarks describe DNR as sequentially up over the last seven quarters, but under direct questioning Grayson added a qualifier that materially softens that claim. The two statements are consistent but read very differently. | “on a rounded basis, it's been flat for the past few” | 2000673338 | 61 |
| New product vocabulary in Q1 2027 shifts IAM from repository and workflow language to agentic and system-of-action language, tracking the MCP and model-partner theme rather than any change in the disclosed financial framework. | “At Momentum, we introduced agentic offerings that advance IAM's transformation into a system of action.” | 2000673338 | 2 |
| Thygesen's response to the sharpest challenge of the latest call is defensive in a way earlier answers were not, opening with a denial that a commitment existed rather than with evidence. | “I don't know that we ever set a time line. I'm not disappointed with our progress.” | 2000673338 | 21 |
The call history supports the operational case and leaves the valuation case open. Retention, consumption and margin have improved steadily over the past 3 years, and IAM has gone from a launch to a guided share of ARR without a visible stumble. What the transcript history does not contain is a disclosed uplift rate for IAM, a date for double-digit growth, or a billings-style check on bookings now that the metric has been retired. The debate therefore rests on whether the 8.5% ARR guide converts into the acceleration management has described, and investors have less independent evidence with which to test that than they had a year ago.